FDA had authorized Dr. Burzynski to conduct trials of antineoplastons as an investigational drug in clinical studies of some cancers and in special exception cases

(4) the FDA had authorized Dr. Burzynski to conduct trials of antineoplastons as an investigational drug in clinical studies of some cancers and in special exception cases
http://caselaw.lp.findlaw.com/data2/californiastatecases/A087171.DOC
Dr. Burzynski had been authorized since 3/1989 by FDA to treat patients clinically with antineoplastons provided I obtained a special exception

Dr. Burzynski states in a declaration:

“I had been authorized since March 1989 by the FDA to treat patients clinically with antineoplastons provided that they were enrolled in a Phase II clinical trial or I obtained a special exception that allowed me to administer treatment that did not meet one or more of the requirements for acceptance into the trial”

the FDA accepted an investigational new drug application (IND) authorizing him

FDA approval
Investigational New Drug (IND)
AIDS

FDA approval on Investigational New Drug (IND) applications for every drug he uses

Advertisements